Variations statin prescribing pattern and LDL goal attainment for secondary prevention of atherosclerotic cardiovascular disease by language and race

IF 3.6 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Meera Gopinath MD, Danielle Scerbo DO, Aimee Willett DO, Mariah Barlow MD, Hector Santiago MD
{"title":"Variations statin prescribing pattern and LDL goal attainment for secondary prevention of atherosclerotic cardiovascular disease by language and race","authors":"Meera Gopinath MD,&nbsp;Danielle Scerbo DO,&nbsp;Aimee Willett DO,&nbsp;Mariah Barlow MD,&nbsp;Hector Santiago MD","doi":"10.1016/j.jacl.2025.04.063","DOIUrl":null,"url":null,"abstract":"<div><h3>Background/Synopsis</h3><div>Statin therapy is a well-established intervention to reduce the risk of recurrent atherosclerotic cardiovascular events. Recent studies have demonstrated statin prescription rates for primary and secondary prevention may be sub-optimal. There is limited information on how unmodifiable patient demographics—such as race and spoken language—affect statin prescribing and LDL-C goal attainment in patients with established CAD. Evaluating statin prescribing patterns and LCL-C target achievement across these demographics will help to identify areas for future intervention and to prevent further cardiovascular events equitably.</div></div><div><h3>Objective/Purpose</h3><div>Our study aims to determine whether the frequency of high intensity statin prescription and attainment of LDL-C &lt; 70 mg/dL for secondary prevention of atherosclerotic cardiovascular disease differs as a function of spoken language and race/ethnicity amongst patients with documented coronary artery disease.</div></div><div><h3>Methods</h3><div>This is a retrospective case control study performed at a multi-site health system. Patients were included in the study if they were over the age of 18, attended an outpatient office encounter at a primary care or cardiovascular medicine office between 01/01/2023 and 09/30/2023 and had a documented diagnosis of coronary artery disease based on ICD-10 codes and billing data during this period.</div></div><div><h3>Results</h3><div>Among the 6,428 patients analyzed, 5,625 were Caucasian and 802 were non-Caucasian. The average LDL cholesterol (LDL-C) for Caucasian patients was 75.87 mg/dL, while for non-Caucasian patients it was 84.1 mg/dL (p-value of &lt;0.001). Statin prescription rates were 70.86% for Caucasians and 65.89% for non-Caucasians (p = 0.004). Regarding language, 6,375 patients were English speakers and 185 were non-English speakers. The average LDL-C for English speakers was 76.85 mg/dL, compared to 79.41 mg/dL for non-English speakers (p = 0.444). Statin prescriptions were higher among English speakers than non-English speakers (70.45% vs 59.17%; p = 0.007).</div></div><div><h3>Conclusions</h3><div>Amongst patients with CAD, non-Caucasian patients and those whose primary language is anything other than English are less likely to achieve LDL-C levels &lt; 70 mg/dL in accordance with ACC guidelines as compared to their English speaking or Caucasian counterparts. This may largely be related to variations in high intensity prescribing patterns between these groups. These findings highlight demographic disparities in LDL-C goal attainment and statin prescribing patterns, emphasizing the need for targeted interventions to improve cardiovascular care equity.</div></div>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":"19 3","pages":"Page e47"},"PeriodicalIF":3.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1933287425001394","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Synopsis

Statin therapy is a well-established intervention to reduce the risk of recurrent atherosclerotic cardiovascular events. Recent studies have demonstrated statin prescription rates for primary and secondary prevention may be sub-optimal. There is limited information on how unmodifiable patient demographics—such as race and spoken language—affect statin prescribing and LDL-C goal attainment in patients with established CAD. Evaluating statin prescribing patterns and LCL-C target achievement across these demographics will help to identify areas for future intervention and to prevent further cardiovascular events equitably.

Objective/Purpose

Our study aims to determine whether the frequency of high intensity statin prescription and attainment of LDL-C < 70 mg/dL for secondary prevention of atherosclerotic cardiovascular disease differs as a function of spoken language and race/ethnicity amongst patients with documented coronary artery disease.

Methods

This is a retrospective case control study performed at a multi-site health system. Patients were included in the study if they were over the age of 18, attended an outpatient office encounter at a primary care or cardiovascular medicine office between 01/01/2023 and 09/30/2023 and had a documented diagnosis of coronary artery disease based on ICD-10 codes and billing data during this period.

Results

Among the 6,428 patients analyzed, 5,625 were Caucasian and 802 were non-Caucasian. The average LDL cholesterol (LDL-C) for Caucasian patients was 75.87 mg/dL, while for non-Caucasian patients it was 84.1 mg/dL (p-value of <0.001). Statin prescription rates were 70.86% for Caucasians and 65.89% for non-Caucasians (p = 0.004). Regarding language, 6,375 patients were English speakers and 185 were non-English speakers. The average LDL-C for English speakers was 76.85 mg/dL, compared to 79.41 mg/dL for non-English speakers (p = 0.444). Statin prescriptions were higher among English speakers than non-English speakers (70.45% vs 59.17%; p = 0.007).

Conclusions

Amongst patients with CAD, non-Caucasian patients and those whose primary language is anything other than English are less likely to achieve LDL-C levels < 70 mg/dL in accordance with ACC guidelines as compared to their English speaking or Caucasian counterparts. This may largely be related to variations in high intensity prescribing patterns between these groups. These findings highlight demographic disparities in LDL-C goal attainment and statin prescribing patterns, emphasizing the need for targeted interventions to improve cardiovascular care equity.
不同语言和种族的他汀类药物处方模式和低密度脂蛋白目标实现对动脉粥样硬化性心血管疾病二级预防的影响
背景/摘要他汀类药物治疗是一种行之有效的干预措施,可降低动脉粥样硬化性心血管事件复发的风险。最近的研究表明,一级和二级预防的他汀类药物处方率可能不是最佳的。关于不可改变的患者人口统计数据(如种族和口语)如何影响已确诊CAD患者的他汀类药物处方和LDL-C目标实现的信息有限。在这些人群中评估他汀类药物的处方模式和低密度脂蛋白- c目标的实现将有助于确定未来干预的领域,并公平地预防进一步的心血管事件。目的/目的本研究旨在确定高强度他汀类药物的使用频率和LDL-C及lt的达到情况;70 mg/dL对动脉粥样硬化性心血管疾病的二级预防作用因有记录的冠状动脉疾病患者的口语和种族而异。方法本研究是在一个多地点卫生系统进行的回顾性病例对照研究。如果患者年龄超过18岁,在2023年1月1日至2023年9月30日期间在初级保健或心血管医学办公室门诊就诊,并且在此期间根据ICD-10代码和计费数据记录了冠状动脉疾病的诊断,则将其纳入研究。结果6428例患者中,5625例为白种人,802例为非白种人。白种人患者的平均LDL- c为75.87 mg/dL,非白种人患者的平均LDL- c为84.1 mg/dL (p值为<;0.001)。白种人的他汀类药物处方率为70.86%,非白种人为65.89% (p = 0.004)。在语言方面,6375名患者为英语患者,185名患者为非英语患者。英语使用者的平均LDL-C为76.85 mg/dL,而非英语使用者为79.41 mg/dL (p = 0.444)。他汀类药物处方在英语人群中的比例高于非英语人群(70.45% vs 59.17%; = 0.007页)。结论在冠心病患者中,非白种人患者和母语非英语的患者达到LDL-C水平的可能性较低。70毫克/分升与说英语的人或白种人相比这可能在很大程度上与这些群体之间高强度处方模式的差异有关。这些发现强调了LDL-C目标实现和他汀类药物处方模式的人口差异,强调需要有针对性的干预措施来改善心血管护理的公平性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.00
自引率
6.80%
发文量
209
审稿时长
49 days
期刊介绍: Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信